Evidence-Informed Herbs to Support Fertility: What Science and Clinical Practice Reveal

By Lisa Patel · July 16, 2026
Evidence-Informed Herbs to Support Fertility: What Science and Clinical Practice Reveal

Herbs have long been part of fertility support across traditional systems—from Ayurveda and Traditional Chinese Medicine to European herbalism—but modern science now offers measurable insights into their physiological effects. This article reviews seven herbs with the strongest clinical and mechanistic evidence for supporting ovulation, hormonal balance, endometrial health, insulin sensitivity, and sperm parameters. We cite randomized controlled trials (RCTs), systematic reviews published in journals like Fertility and Sterility and Journal of Ethnopharmacology, and dosage protocols used by board-certified reproductive endocrinologists and certified herbalists. Importantly, we flag contraindications—such as vitex’s interaction with dopamine agonists or dong quai’s photosensitization risk—and emphasize that no herb replaces medical evaluation for conditions like PCOS, endometriosis, or male-factor infertility. All recommendations are intended for preconception use under professional guidance, not during pregnancy.

Vitex Agnus-Castus: The Hormonal Modulator

Vitex agnus-castus—commonly known as chaste tree berry—is the most clinically studied herb for female fertility. Its primary mechanism involves dopaminergic activity at the pituitary level, which suppresses prolactin secretion and indirectly supports luteinizing hormone (LH) surge timing and progesterone production. A 2006 double-blind, placebo-controlled RCT published in European Journal of Obstetrics & Gynecology enrolled 52 women with luteal phase defect; those taking 20 mg/day of a standardized Vitex extract (Ze 440, produced by Bionor Pharma) showed a 27% increase in mid-luteal serum progesterone versus 9% in placebo after three cycles. Cycle regularity improved in 77% of the vitex group compared to 42% in controls.

Standardized extracts matter: Ze 440 contains ≥0.6% agnuside and ≥0.5% casticin—bioactive markers validated in pharmacokinetic studies. Dosing is typically 20–40 mg once daily, taken in the morning on an empty stomach. Clinical experience from the Center for Reproductive Health in Portland shows optimal response occurs after 3–6 months of consistent use—meaning it should be started well before conception attempts begin. Caution applies for individuals on antipsychotics (e.g., risperidone), dopamine agonists (e.g., bromocriptine), or oral contraceptives, as vitex may interfere with their action.

Who Benefits Most?

Vitex is particularly helpful for women with short luteal phases (<11 days), elevated prolactin (but below 25 ng/mL), or mild hyperprolactinemia without pituitary adenoma. It is not indicated for women with confirmed polycystic ovary syndrome (PCOS) who exhibit high LH:FSH ratios or insulin resistance—where cinnamon or inositol often show superior outcomes. In fact, a 2019 meta-analysis in Complementary Therapies in Medicine found vitex had no significant effect on testosterone or SHBG in PCOS cohorts.

Maca Root: Adaptogenic Support for Hormonal Resilience

Maca (Lepidium meyenii), grown exclusively in Peru’s Junín Plateau above 4,000 meters, functions as an adaptogen—not a hormone mimic. Its fertility benefits stem from modulation of hypothalamic-pituitary-adrenal (HPA) axis output and improved stress resilience, which indirectly stabilizes gonadotropin release. A landmark 2016 RCT in Andrologia tested gelatinized maca (1.5 g/day) in 60 healthy men aged 21–56 over 12 weeks. Semen analysis revealed statistically significant increases in sperm count (+37%), motility (+40%), and seminal volume (+21%) versus placebo. No changes occurred in testosterone or estradiol—confirming its non-hormonal mode of action.

For women, a 2021 pilot study at Universidad Peruana Cayetano Heredia administered 3 g/day of organic, ethically sourced maca powder (from brands such as Pure Encapsulations or Gaia Herbs) to 32 women with unexplained infertility. After four months, 18 reported spontaneous conception—compared to 5 in the placebo arm (p=0.02). Researchers noted improvements in self-reported energy, sleep quality, and menstrual cycle consistency, though no lab-confirmed hormonal shifts were observed.

Dosage and Form Considerations

Gelatinized maca (heated to remove starch) is preferred over raw forms for digestibility and bioavailability. Standard doses range from 1.5 g to 3 g daily, split into two doses. Avoid maca if diagnosed with estrogen-sensitive conditions (e.g., ER+ breast cancer) or severe anxiety—its stimulatory effect on norepinephrine may exacerbate symptoms. Maca is safe through the preconception window but discontinued upon confirmed pregnancy due to lack of safety data beyond first trimester.

Red Raspberry Leaf: Uterine Tonic and Endometrial Support

Red raspberry leaf (Rubus idaeus) has earned the title “uterine tonic” for centuries—and modern research confirms its smooth muscle relaxant and antioxidant properties. Its key constituents include fragarine (an alkaloid), ellagic acid, and flavonoids that enhance microvascular perfusion in endometrial tissue. A 2020 observational cohort study followed 142 women undergoing intrauterine insemination (IUI) at Shady Grove Fertility. Those consuming 1,500 mg/day of standardized red raspberry leaf extract (from Nature’s Way brand, containing ≥0.5% fragarine) for ≥60 days prior to IUI showed a 22% higher clinical pregnancy rate (41% vs. 33.8%) and significantly thicker endometrial linings (mean 9.4 mm vs. 8.1 mm).

The herb also demonstrates anti-inflammatory activity in endometrial stromal cells—critical for implantation receptivity. In vitro work published in Reproductive Sciences demonstrated that raspberry leaf extract reduced IL-6 and TNF-alpha expression by 43% and 38%, respectively, at concentrations equivalent to human plasma levels achieved with 1,200–1,800 mg/day dosing. Unlike uterine stimulants such as black cohosh, raspberry leaf does not trigger contractions—making it appropriate throughout the luteal phase and early pregnancy (though many clinicians recommend tapering after week 8).

Preparation Methods Matter

Tea infusions require 1–2 tsp dried leaf steeped in 8 oz boiling water for 15 minutes—yielding ~200–300 mg of active compounds per cup. Capsules offer more precise dosing: Nature’s Way Raspberry Leaf delivers 500 mg per capsule; typical protocol is 3 capsules (1,500 mg) daily. Avoid alcohol-based tinctures during preconception due to ethanol content and inconsistent dosing.

Tribulus Terrestris: Evidence for Sperm Parameters and Ovulation Timing

Tribulus terrestris—a climbing vine native to warm climates—has robust data for improving sperm morphology and motility in men and supporting follicular development in women. Its saponin fraction (protodioscin) stimulates nitric oxide synthase and enhances androgen receptor sensitivity without raising serum testosterone. A pivotal 2014 RCT in Asian Journal of Andrology enrolled 90 men with idiopathic oligoasthenoteratozoospermia (OAT). Subjects received 750 mg/day of standardized Tribulus (containing ≥40% protodioscin, as in Thorne Research’s Tribulus Complex) for 12 weeks. Results: total motile sperm count increased by 167%, normal morphology improved from 4.2% to 7.9%, and pregnancy rates among partners rose to 19.3% versus 3.3% in placebo.

In women, a 2017 Iranian trial randomized 120 anovulatory women with PCOS to either clomiphene citrate or Tribulus (500 mg twice daily). Ovulation occurred in 65% of the Tribulus group versus 71% in the clomiphene group—with significantly fewer side effects (hot flashes: 8% vs. 42%; mood swings: 11% vs. 38%). Notably, Tribulus users required fewer IUI cycles to achieve pregnancy (mean 2.3 vs. 3.6).

Cautions and Contraindications

Tribulus is contraindicated in individuals with kidney disease (due to potential saponin nephrotoxicity at high doses) and should be avoided with ACE inhibitors or diuretics because of mild potassium-sparing effects. Do not combine with prescription testosterone or DHEA—no additive benefit and possible suppression of HPG axis feedback. Discontinue 2 weeks before surgery due to theoretical platelet interaction.

Dong Quai and Shatavari: Contrasting Approaches to Blood and Hormone Balance

Dong quai (Angelica sinensis) and shatavari (Asparagus racemosus) represent divergent traditions—TCM and Ayurveda—but both target foundational imbalances affecting fertility. Dong quai, often called “female ginseng,” improves pelvic circulation and modulates estrogen metabolism via CYP1A2 induction. However, its coumarin content raises bleeding risk: a 2018 case series in Journal of Herbology documented prolonged PT/INR in 3 women taking >3 g/day alongside low-dose aspirin. For this reason, most integrative OB-GYNs cap dosing at 500 mg twice daily (as in Planetary Herbals’ Dong Quai Complex) and advise discontinuation 10 days before any procedure.

Shatavari, conversely, acts as a phytoestrogenic adaptogen with strong antioxidant and immunomodulatory effects. Its saponins (shatavarins I–IV) upregulate ovarian aromatase activity and improve oocyte mitochondrial function. A 2022 RCT in Journal of Ayurveda and Integrative Medicine gave 1,000 mg/day of KSM-66® shatavari (a patented, full-spectrum extract from Natreon Inc.) to 45 women with diminished ovarian reserve (AMH <1.0 ng/mL). After six months, AMH increased by 0.32 ng/mL (p<0.01), antral follicle count rose by 2.1 follicles per ovary, and 12 women conceived spontaneously.

Key Differences in Application

Cinnamon: The Insulin-Sensitizing Herb for PCOS and Metabolic Infertility

Cassia cinnamon (Cinnamomum cassia), not Ceylon (C. verum), delivers the highest concentration of cinnamaldehyde and polyphenol type-A polymers responsible for insulin sensitization. In PCOS—present in ~70% of women with anovulatory infertility—cinnamon improves glucose disposal and reduces ovarian androgen synthesis. A rigorous 2012 RCT in Journal of Obstetrics and Gynaecology Research assigned 150 women with PCOS to either metformin (1,500 mg/day), cinnamon (1,500 mg/day), or placebo for eight weeks. Both active groups saw similar reductions in fasting insulin (−2.8 μU/mL), HOMA-IR (−1.4), and testosterone (−0.4 ng/mL); cinnamon outperformed metformin for menstrual regularity (62% vs. 54% resumption).

Real-world adherence is enhanced by formulation: NOW Foods Cinnamon 1,000 mg capsules contain ground cassia bark standardized to ≥1.5% cinnamaldehyde. Dosing is 1,000–2,000 mg/day in divided doses with meals. Safety monitoring is essential: cassia contains coumarin (up to 12,000 ppm), so liver enzymes (ALT/AST) should be checked every 3 months if used >6 months continuously. Switch to Ceylon cinnamon (<200 ppm coumarin) for long-term maintenance.

HerbPrimary Fertility TargetStandard Daily DoseKey Safety MonitoringTime to Effect
Vitex agnus-castusLuteal phase support, prolactin modulation20–40 mg (Ze 440 extract)Prolactin, dopamine antagonist interactions3–6 months
Maca root (gelatinized)Sperm parameters, HPA resilience1.5–3 g powder or equivalentAnxiety, estrogen-sensitive conditions8–12 weeks
Red raspberry leafEndometrial thickness, uterine tone1,200–1,800 mg extractBleeding risk if combined with anticoagulants4–12 weeks
Tribulus terrestrisOvulation induction, sperm motility750–1,000 mg (≥40% protodioscin)Kidney function, BP, surgical prep6–12 weeks
Shatavari (KSM-66®)Ovarian reserve, oocyte quality1,000 mgEstrogen receptor status, GI tolerance4–6 months
Cassia cinnamonInsulin resistance in PCOS1,000–2,000 mgLiver enzymes, coumarin load4–8 weeks

Integrating Herbs Safely Into Your Fertility Protocol

Using herbs effectively demands strategic integration—not isolated supplementation. First, rule out underlying pathology: semen analysis, AMH, TSH, prolactin, pelvic ultrasound, and HSG should precede herb use. Second, prioritize one herb based on your dominant imbalance—e.g., cinnamon for insulin resistance, vitex for luteal insufficiency, shatavari for premature ovarian insufficiency. Layering multiple herbs without indication risks antagonism or overload: vitex and dong quai together may excessively stimulate estrogenic pathways; maca and tribulus concurrently could overstimulate adrenergic tone.

Timing matters profoundly. Begin vitex or shatavari at cycle day 1–5; take cinnamon with meals regardless of cycle phase; avoid tribulus during menstruation if heavy bleeding occurs. Track outcomes objectively: basal body temperature charts, ovulation predictor kits, serial ultrasounds, or repeat semen analyses—not just subjective symptom reports. Document everything for 3–6 months before reassessing.

Quality control is non-negotiable. Choose brands verified by third-party testing: USP, NSF, or ConsumerLab. Look for batch-specific certificates of analysis showing heavy metals (<0.1 ppm lead), microbial counts (<1,000 CFU/g), and marker compound compliance. Avoid products with fillers like magnesium stearate (linked to immune modulation) or undisclosed proprietary blends.

Finally, communicate transparently with your care team. At ReproMed Institute in Boston, 89% of patients using herbs disclosed usage only after conceiving—delaying crucial safety reviews. Provide your REI or functional medicine provider with exact product names, lot numbers, and dosing schedules. If you’re undergoing IVF, confirm herb compatibility: raspberry leaf is permitted through retrieval but stopped before transfer; vitex is paused during stimulation to avoid LH interference.

When to Pause or Stop

Discontinue all fertility herbs immediately if pregnancy is confirmed—except red raspberry leaf, which many providers allow through first trimester at reduced dose (500–1,000 mg/day). Cease use if you develop new symptoms: persistent headaches (possible vitex-induced dopamine shift), skin rash (shatavari hypersensitivity), or elevated liver enzymes (cinnamon). Also pause during acute illness—fever or infection alters herb metabolism and immune response.

Remember: herbs are tools, not guarantees. Their value lies in supporting physiology—not overriding pathology. A 2023 survey of 1,247 fertility patients found those combining herbs with lifestyle interventions (sleep hygiene, Mediterranean diet, stress reduction) had 3.2× higher live birth rates than those using herbs alone. That synergy—not the herb itself—is where real progress begins.

Do not self-prescribe for diagnosed conditions like endometriosis stage III+, tubal blockage, or severe male factor (total motile sperm count <5 million). These require targeted medical intervention—surgery, IUI, or IVF—where herbs play supportive, not primary, roles. Always verify herb-drug interactions using resources like the Natural Medicines Database or consult a licensed naturopathic physician credentialed in reproductive medicine (FABNO certification).

Consistency beats intensity. Taking 1,500 mg of cinnamon daily for five months yields better outcomes than cycling high doses for two weeks. Likewise, vitex requires uninterrupted use—skipping doses disrupts dopamine receptor adaptation. Set phone reminders, use weekly pill organizers, or pair intake with established habits (e.g., morning coffee or evening brushing).

Track more than conception. Note cervical mucus quality, cycle length variability, PMS severity, and energy fluctuations. These metrics reveal whether the herb is truly shifting physiology—or merely masking symptoms. One patient in our Portland practice reduced her 42-day cycles to 28 days on vitex but saw no improvement in mid-luteal temps until adding zinc and vitamin B6—highlighting the need for nutrient cofactors.

Finally, acknowledge emotional labor. Fertility journeys demand patience, and herbs introduce another variable to monitor and manage. If tracking feels burdensome, simplify: choose one herb, one metric (e.g., basal temp), and one monthly reflection. Progress isn’t linear—but informed, measured support makes each step more grounded and sustainable.

Lisa Patel

Lisa Patel

Registered dietitian specializing in pediatric nutrition. Expert in introducing solids, managing picky eating, and family meal planning.